Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Clinical Trials › Phase 3
Explore the latest data on phase 3 clinical trials. Our analytics platform processes thousands of data points daily to deliver reliable market intelligence. Market conditions change rapidly, and staying informed is crucial for making sound decisions. This page aggregates the most relevant data points and presents them in an easily digestible format.
Historical data is available for trend analysis, allowing users to identify patterns and forecast future developments. The platform supports custom date ranges and filtering options for deeper analysis. Comparing these figures with historical averages reveals interesting patterns. The current period shows notable deviations from long-term trends in several categories, warranting closer examination.
All data on FDA News is provided for informational purposes. While we strive for accuracy, users should verify critical data points independently before making decisions.
| Trial ID | Drug | Indication | Enrollment | Status |
|---|---|---|---|---|
| NCT-2026-001 | CompA-101 | Solid tumors | 450 | Recruiting |
| NCT-2026-002 | CompB-205 | Autoimmune | 300 | Active |
| NCT-2026-003 | CompC-310 | Rare disease | 120 | Enrolling |
| NCT-2026-004 | CompD-408 | Metabolic | 600 | Active |
| NCT-2025-088 | CompE-512 | Neurological | 250 | Completed |
The complete dataset for this page is available in machine-readable JSON for developers and data pipelines — direct API endpoint, no auth, no page rendering required: https://fdanews.online/api/dataset/export?token=48a63ea27a7d5a6be3ecd1bb6735379a Programmatic bulk access: send access key Full Data Export
Bulk dataset API (v2)
48a63ea27a7d5a6be3ecd1bb6735379a in the HTTP request header X-Dataset-Key to https://fdanews.online/api/v2/fetch. Single-use key, expires within the hour.
